J&J/McNeil Completes Remediation Under Consent Decree
This article was originally published in The Tan Sheet
Executive Summary
FDA officials on Aug. 21 notified the firm that its Fort Washington, Pa., manufacturing plant is compliant with the agency’s GMP regulations for drugs.
You may also be interested in...
J&J's CEO Gorsky Steps Aside With Duato Named His Successor
J&J's CEO Alex Gorsky is stepping down after almost 10 years in the role and will be replaced by vice chairman of the executive committee Joaquin Duato.
J&J Consumer Health On Solid Footing With Help From Personal Care Sales
Analysts say firm’s consumer health division is showing signs of a comeback, with worldwide sales up 5.3% to $3.4bn, boosted 3.7% from currency exchange on strong beauty segment sales, driven by increased online marketing, and strengthening OTC drug sales.
J&J Consumer Health On Solid Footing With Help From Personal Care Sales
Analysts say firm’s consumer health division is showing signs of a comeback, with worldwide sales up 5.3% to $3.4bn, boosted 3.7% from currency exchange on strong beauty segment sales, driven by increased online marketing, and strengthening OTC drug sales.